REG - Bank of NY Mel Corp Medtronic, Inc. - Form 8.3 - Medtronic Inc. <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 3307TBank of New York Mellon Corp. (The)02 October 2014Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
The Bank of New York Mellon Corporation and its subsidiaries; 1. The Bank of New York Mellon, 2. The Dreyfus Corporation, 3. BNY Mellon Service Kapitalanlage-Gesellschaft mbH, 4. Lockwood Advisors, Inc. 5. Mellon Capital Management Corporation, 6. BNY Mellon Trust Company (Cayman) Limited, 7. BNY Mellon Trust of Delaware, 8. BNY Mellon, National Association, 9. The Boston Company Asset Management LLC, 10. MBSC Securities Corporation, 11. BNY Mellon Capital Markets, LLC 12. Newton Investment Management Limited, 13. Newton Capital Management Limited
Companydealtin
Medtronic Inc
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
$0.10 Common Shares
Dateofdealing
01 October 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
17,214,940 1.76%
90 0.00001%
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
17,214,940 1.76%
90 0.00001%
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Sale
Transfer in
PurchasePurchase
Purchase
Transfer Out
SaleSale
Purchase
Sale260
642
5,500210
5,673
13,170
5,50012,343
14,365
14,364USD 62.47
N/A
USD 61.95USD 62.47
USD 61.81
N/A
USD 61.95USD 61.95
USD 61.95
USD 62.16(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)
(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)
(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)
Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofany
relevantsecuritiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,
this shouldbestated.
None
IsaSupplementalForm8attached?(Note9) NO
Dateofdisclosure
2 October 2014
Contactname
Ivan Arias
Telephonenumber
1-516-338-3370
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected
IfaconnectedEFM,statenatureofconnection(Note10)
This information is provided by RNSThe company news service from the London Stock ExchangeENDISELLFLSILLFIIS
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement